EyePoint Pharmaceuticals Inc EYPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
12.52quote price arrow down-0.42 (-3.25%)
Volume
1,083,886
52 week range
5.67 - 30.99
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.52
  • 52 Week High30.99
  • 52 Week High Date02/08/24
  • 52 Week Low5.67
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap652.094M
  • Shares Out52.08M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-44.01

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.52
  • 52 Week High30.99
  • 52 Week High Date02/08/24
  • 52 Week Low5.67
  • 52 Week Low Date10/30/23
  • Market Cap652.094M
  • Shares Out52.08M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.61
  • YTD % Change-44.01

RATIOS/PROFITABILITY

  • EPS (TTM)-1.83
  • P/E (TTM)-6.86
  • Fwd P/E (NTM)-5.63
  • EBITDA (TTM)-86.172M
  • ROE (TTM)-48.07%
  • Revenue (TTM)50.019M
  • Gross Margin (TTM)90.50%
  • Net Margin (TTM)-157.77%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On EyePoint Pharmaceuticals Inc

Profile

MORE
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. The Company's pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases....
Nancy Lurker
Executive Vice Chairman of the Board
Goran Ando M.D.
Non-Executive Independent Chairman of the Board
Jay Duker M.D.
President, Chief Executive Officer
George Elston
Chief Financial Officer, Executive Vice President
Address
480 Pleasant St Ste B300
Watertown, MA
02472-2468
United States

Top Peers

SYMBOLLASTCHG%CHG
SIGA
SIGA Technologies Inc
7.90+0.10+1.28%
OCUL
Ocular Therapeutix Inc
6.27-0.02-0.32%
AQST
Aquestive Therapeutics Inc
3.28+0.06+1.86%
HROW
Harrow Inc
16.16+0.23+1.48%
CDXC
Chromadex Corp
3.48-0.15-4.13%